{"disease":{"id":"upper-urinary-tract-urothelial-carcinoma","name":"upper urinary tract urothelial carcinoma"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07077447","title":"The Danish Bladder Cancer Group 23 Study - A European Study on Cancer in the Upper Urinary Tract","phase":"","overall_status":"RECRUITING","enrollment_count":2500,"lead_sponsor_name":"Zealand University Hospital","has_results":false},{"nct_id":"NCT06169436","title":"Translational Cancer Observational Protocol","phase":"","overall_status":"RECRUITING","enrollment_count":1250,"lead_sponsor_name":"IRCCS San Raffaele","has_results":false},{"nct_id":"NCT05810623","title":"Single-Dose Intravesical Chemotherapy After Diagnostic URS","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":394,"lead_sponsor_name":"David D'Andrea","has_results":false},{"nct_id":"NCT07492225","title":"Neoadjuvant Chemotherapy Before Surgery vs Surgery Alone for UTUC: A Randomized Trial","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":120,"lead_sponsor_name":"Changhai Hospital","has_results":false},{"nct_id":"NCT06210490","title":"A Clinical Study of the Efficacy and Safety of Disitamab Vedotin in Combination With Radiotherapy for the Adjuvant Treatment of HER2 Overexpressing UTUC Patients With High Risk Factors for Recurrence After Radical Surgery","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Peking University First Hospital","has_results":false},{"nct_id":"NCT05160285","title":"Neoadjuvant Nivolumab for Upper Tract Urothelial Carcinoma","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":29,"lead_sponsor_name":"YULISU","has_results":false},{"nct_id":"NCT04944550","title":"New Models for the Evaluation of Preclinical Treatment for Urothelial Carcinomas of the Upper Excretory Tract.","phase":"","overall_status":"UNKNOWN","enrollment_count":20,"lead_sponsor_name":"Centre Hospitalier Universitaire de Nīmes","has_results":false},{"nct_id":"NCT04672317","title":"Neoadjuvant PD-1 Monoclonal Antibody Plus Cisplatin-based Chemotherapy in Locally Advanced Upper Tract Urothelial Carcinoma","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":20,"lead_sponsor_name":"RenJi Hospital","has_results":false},{"nct_id":"NCT06354231","title":"DV Combined With Toripalimab for Renal Preservation in Solitary Kidney or Renal Insufficiency or Bilateral Multiple UTUC","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT05912816","title":"Combination of DV and Tislelizumab for Renal Preservation in High-risk UTUC Patients","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"RenJi Hospital","has_results":false},{"nct_id":"NCT04672330","title":"Neoadjuvant PD-1 Monoclonal Antibody in Cisplatin-ineligible High Risk Upper Tract Urothelial Carcinoma","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":16,"lead_sponsor_name":"RenJi Hospital","has_results":false}],"total":11},"guidelines":[],"source":"Drug Landscape verified database"}